American Society Of Clinical Oncology

The news of daraxonrasib's success is a scientific breakthrough and just the beginning of a new era of RAS inhibitors.

A large national clinical trial funded by the Patient-Centered Outcomes Research Institute (PCORI) has shown outstanding early outcomes for prostate cancer patients treated with both proton therapy and standard photon radiation therapy. Nancy Mendenhall, M.D. Nancy Mendenhall, M.D., medical director of the UF Health Proton Therapy Institute,…

An ultra-sensitive liquid biopsy test that assesses DNA shed by tumors in the bloodstream may help doctors better monitor how patients with advanced GI cancers respond to treatment.

The UF Health Cancer Institute will showcase the breadth of its innovative research at the 2026 ASCO Annual Meeting.

ASCO fellow designation recognizes extraordinary volunteer service, engagement and dedication.

In an interview with Healio, Erin Mobley, Ph.D., discussed her study on the cardioprotective effects of dexrazoxane in pediatric cancer survivors.

The award recognizes her research on cardiac function after doxorubicin and dexrazoxane.

Researchers combed through data about whether outdated cancer screenings were still being used.

The study identified four areas of support that need to be integrated into adolescent and young adult (AYA) cancer care.

UF Health medical oncologist Daniel Araujo, M.D., has been selected for two ASCO professional development programs.